
🫁 It’s the epithelium, not myeloid cells. Epithelial NLRP3 drives lung injury and fibrosis via IL‑18 and pro‑fibrotic neutrophils. doi.org/10.1186/s12989-026-0…

The Viral Immunity and Immunopathology Laboratory at @Hudson_Research @CiiiD_Research Host-directed therapies for #influenza and pulmonary inflammation

🫁 It’s the epithelium, not myeloid cells. Epithelial NLRP3 drives lung injury and fibrosis via IL‑18 and pro‑fibrotic neutrophils. doi.org/10.1186/s12989-026-0…

Although there are no effective drugs for severe influenza, a breakthrough led by @Tate_Lab in collaboration with Associate Professor Ashley Mansell, led to innovative treatments that target the body rather than the virus itself to limit inflammation and save lives. Read more in NHMRC’s 10 of the Best 17th Edition now on our website: ow.ly/yTS850YJiFC

Excited to share our new work in @MucosalImmunol on preventing the #1 killer after flu: secondary bacterial pneumonia mucosalimmunology.org/articl…

Our latest paper on influenza and gasdermin E @CiiiD_Hudson @Hudson_Research nature.com/articles/s41419-0…

Exciting news! The AVS12 Meeting Report is now published in the @ASMicrobiology Journal of Virology 🎉 AVS prides itself on supporting all voices in virology through career development, Indigenous engagement, collaboration, and recognition of excellence. journals.asm.org/doi/10.1128…

🚨 Registrations for #AVS12 are still open! 🚨 📅 Dec 2-5 | 📍 RACV Goldfields, Creswick, VIC Join us for an unforgettable event! 🔗 Register now: avs2024.org

Taking AIM at Influenza: The Role of the AIM2 Inflammasome ✍️by Xu & Tate 👉mdpi.com/1999-4915/16/10/153… #influenza #sensing #immunology

Options for the control of influenza XII Conference #optionsxii2024 Brisbane

Join us this December for AVS2024! Early Bird Registration & Abstract deadline is Friday 9th August Stay Posted here: avs2024.org

When patients with severe flu are admitted to hospital there are no effective drugs available to reduce the response to the virus. Our researchers are focusing on finding treatments to help these patients 2024 flu season guide: bit.ly/4dWolB5 @Tate_Lab @CiiiD_Research

Thrilled to be receiving this award! Massive thanks to the @Lungfoundation and @Tate_Lab for all the support! #TSANZRS2024
Lung Foundation Australia's Hope Research Fund grants for 2024 have been awarded! We would like to offer our congratulations to the early and mid-career PHDs and fellowships awardees 👏

Lung Foundation Australia's Hope Research Fund grants for 2024 have been awarded! We would like to offer our congratulations to the early and mid-career PHDs and fellowships awardees 👏

We are pleased to announce our April #ACDS Seminar will feature @Sarah_Rosli_ @Hudson_Research & Dr Robson Kriiger Loterio @BurnetInstitute! 👏 Join us on Wed 3rd April (11am AEDT on Zoom) to hear how GSDME alters #influenza severity 🫁 and how Coxiella stops host #celldeath! 🦠

Save the date for AVS 2024 2nd– 5th December RACV Goldfields, Creswick, VIC Stay Posted here: avs2024.org/

Congratulations to @DrEmilyGulliver from @Forster_Lab on winning best ECR talk and @Sarah_Rosli_ from @Tate_Lab for winning best student poster at #lorneiandi! What a great meeting which showcased so much of the exciting research ongoing here at CiiiD & @Hudson_Research ! 👏
